Total Payments
$340,429
2024 Payments
$58,189
Companies
25
Transactions
376
Medicare Patients
607
Medicare Billing
$166,202
Payment Breakdown by Category
Consulting$169,484 (49.8%)
Other$99,436 (29.2%)
Travel$49,594 (14.6%)
Food & Beverage$11,257 (3.3%)
Research$10,642 (3.1%)
Education$16.75 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $169,484 | 54 | 49.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $88,523 | 35 | 26.0% |
| Travel and Lodging | $49,594 | 113 | 14.6% |
| Food and Beverage | $11,257 | 167 | 3.3% |
| Unspecified | $10,642 | 2 | 3.1% |
| Honoraria | $10,639 | 3 | 3.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $274.39 | 1 | 0.1% |
| Education | $16.75 | 1 | 0.0% |
Payments by Type
General
$329,787
374 transactions
Research
$10,642
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $160,177 | 165 | $0 (2024) |
| PFIZER INC. | $26,555 | 11 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $26,542 | 12 | $0 (2023) |
| Incyte Corporation | $19,902 | 31 | $0 (2020) |
| Kite Pharma, Inc. | $15,856 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $14,924 | 10 | $0 (2024) |
| SOBI, INC | $13,280 | 21 | $0 (2024) |
| SANOFI US SERVICES INC. | $11,634 | 2 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $8,971 | 20 | $0 (2023) |
| Gilead Sciences, Inc. | $7,901 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58,189 | 54 | Amgen Inc. ($23,259) |
| 2023 | $31,050 | 22 | Amgen Inc. ($8,430) |
| 2022 | $54,829 | 33 | SANOFI-AVENTIS U.S. LLC ($20,042) |
| 2021 | $32,635 | 24 | Amgen Inc. ($11,672) |
| 2020 | $27,415 | 12 | Amgen Inc. ($9,598) |
| 2019 | $27,093 | 56 | Amgen Inc. ($21,494) |
| 2018 | $35,720 | 84 | Amgen Inc. ($11,997) |
| 2017 | $73,498 | 91 | Amgen Inc. ($55,474) |
All Payment Transactions
376 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | SOBI, INC | GAMIFANT (Drug) | Food and Beverage | In-kind items and services | $147.08 | General |
| Category: HEMATOLOGY | ||||||
| 12/08/2024 | SOBI, INC | GAMIFANT (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: HEMATOLOGY | ||||||
| 11/19/2024 | Amgen Inc. | Blincyto (Biological) | — | In-kind items and services | $4,825.31 | Research |
| Study: Frontline Ph-Negative B-Lineage Acute Lymphoblastic Leukemia Treatment and the Emerging Role of Blinatumomab • Category: Oncology | ||||||
| 11/13/2024 | PFIZER INC. | BESPONSA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,695.00 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $8,232.00 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: Oncology | ||||||
| 09/23/2024 | SANOFI US SERVICES INC. | REZUROCK (Drug) | Consulting Fee | Cash or cash equivalent | $5,817.00 | General |
| Category: Oncology | ||||||
| 09/23/2024 | SANOFI US SERVICES INC. | REZUROCK (Drug) | — | Cash or cash equivalent | $5,817.00 | Research |
| Study: DFI - SAR445761 - ROCK2 sm - belumosudil - Rezurock • Category: Oncology | ||||||
| 09/22/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $106.34 | General |
| Category: Oncology | ||||||
| 09/22/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Oncology | ||||||
| 09/22/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Oncology | ||||||
| 09/22/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Oncology | ||||||
| 09/21/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $121.33 | General |
| Category: Oncology | ||||||
| 09/21/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $62.53 | General |
| Category: Oncology | ||||||
| 09/21/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $60.18 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $142.71 | General |
| Category: Oncology | ||||||
| 09/18/2024 | PFIZER INC. | BESPONSA (Biological) | Consulting Fee | Cash or cash equivalent | $1,540.00 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | Amgen Inc. | Blincyto (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,278.40 | General |
| Category: Oncology | ||||||
| 09/04/2024 | PFIZER INC. | BESPONSA (Biological) | Food and Beverage | In-kind items and services | $63.06 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $44.64 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $1,288.00 | General |
| Category: Oncology | ||||||
| 07/14/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $37.93 | General |
| Category: Oncology | ||||||
| 07/13/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $2,362.50 | General |
| 07/13/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $300.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| DFI - SAR445761 - ROCK2 sm - belumosudil - Rezurock | SANOFI US SERVICES INC. | $5,817 | 1 |
| Frontline Ph-Negative B-Lineage Acute Lymphoblastic Leukemia Treatment and the Emerging Role of Blinatumomab | Amgen Inc. | $4,825 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 175 | 403 | $536,550 | $42,935 |
| 2022 | 4 | 170 | 422 | $335,782 | $44,513 |
| 2021 | 4 | 138 | 447 | $322,736 | $50,082 |
| 2020 | 4 | 124 | 316 | $214,696 | $28,671 |
Total Patients
607
Total Services
1,588
Medicare Billing
$166,202
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 81 | 262 | $202,526 | $30,491 | 15.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 50 | $27,550 | $5,366 | 19.5% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2023 | 55 | 65 | $97,664 | $4,289 | 4.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $11,935 | $1,642 | 13.8% |
| 38206 | Collection of stem cells for transplantation | Facility | 2023 | 11 | 15 | $196,875 | $1,148 | 0.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 70 | 235 | $181,655 | $28,103 | 15.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 40 | 122 | $67,222 | $11,105 | 16.5% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2022 | 47 | 52 | $72,800 | $3,503 | 4.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 13 | 13 | $14,105 | $1,803 | 12.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 66 | 266 | $205,618 | $32,896 | 16.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 42 | 151 | $81,988 | $13,733 | 16.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 14 | 14 | $15,190 | $2,328 | 15.3% |
| 38222 | Diagnostic aspirations and biopsies of bone marrow | Facility | 2021 | 16 | 16 | $19,940 | $1,125 | 5.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 56 | 187 | $144,551 | $17,097 | 11.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 37 | 90 | $47,880 | $8,521 | 17.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 18 | 25 | $14,425 | $1,770 | 12.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 13 | 14 | $7,840 | $1,283 | 16.4% |
About Aaron Logan, MD, PHD
Aaron Logan, MD, PHD is a Internal Medicine healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1801076633.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Aaron Logan, MD, PHD has received a total of $340,429 in payments from pharmaceutical and medical device companies, with $58,189 received in 2024. These payments were reported across 376 transactions from 25 companies. The most common payment nature is "Consulting Fee" ($169,484).
As a Medicare-enrolled provider, Logan has provided services to 607 Medicare beneficiaries, totaling 1,588 services with total Medicare billing of $166,202. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology, Hematology
- Location San Francisco, CA
- Active Since 11/09/2007
- Last Updated 09/17/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801076633
Products in Payments
- Blincyto (Biological) $114,536
- REZUROCK (Drug) $21,788
- Tecartus (Drug) $18,424
- BESPONSA (Biological) $15,737
- GAMIFANT (Drug) $13,280
- RYDAPT (Drug) $9,487
- VYXEOS (Drug) $5,740
- BOSULIF (Drug) $5,550
- REBLOZYL (Biological) $5,338
- ONCASPAR (Biological) $5,076
- TIBSOVO (Drug) $4,904
- ICLUSIG (Drug) $3,140
- CIBINQO (Drug) $2,700
- clonoSEQ (Device) $2,641
- IMBRUVICA (Drug) $2,544
- ONUREG (Drug) $2,443
- Defitelio (Drug) $2,121
- Kyprolis (Biological) $1,955
- VENCLEXTA (Drug) $1,654
- Imbruvica (Drug) $1,215
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in San Francisco
Dr. Fred Cohen, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
John Teerlink, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Kenneth Binmoeller, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Hope Rugo, Md, MD
Internal Medicine — Payments: $881,117
Internal Medicine $881,117
Dr. Steven Harris, M.d, M.D
Internal Medicine — Payments: $806,637
Internal Medicine $806,637
Dr. Kenneth Colley, Md, MD
Internal Medicine — Payments: $732,736
Internal Medicine $732,736